Refractory Myeloid Neoplasm
1 clinical trials · Condition
◉ Watch Refractory Myeloid Neoplasm
| Record | Firm | Date |
|---|---|---|
| Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms (NCT04797767) | University of Washington | 2022-02-04 |
Track Refractory Myeloid Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.